Patrick Vizeli

1.7k total citations · 1 hit paper
33 papers, 1.2k citations indexed

About

Patrick Vizeli is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Patrick Vizeli has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Clinical Psychology, 16 papers in Cellular and Molecular Neuroscience and 11 papers in Toxicology. Recurrent topics in Patrick Vizeli's work include Psychedelics and Drug Studies (28 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Forensic Toxicology and Drug Analysis (11 papers). Patrick Vizeli is often cited by papers focused on Psychedelics and Drug Studies (28 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Forensic Toxicology and Drug Analysis (11 papers). Patrick Vizeli collaborates with scholars based in Switzerland, Germany and United States. Patrick Vizeli's co-authors include Matthias E. Liechti, Friederike Holze, Felix Müller, Laura Ley, Stefan Borgwardt, Anne Eckert, Nimmy Varghese, Urs Duthaler, Patrick C. Dolder and Yasmin Schmid and has published in prestigious journals such as PLoS ONE, Scientific Reports and Neuropsychopharmacology.

In The Last Decade

Patrick Vizeli

31 papers receiving 1.2k citations

Hit Papers

Direct comparison of the acute effects of lysergic acid d... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Vizeli Switzerland 20 1.1k 633 531 267 200 33 1.2k
Ben Sessa United Kingdom 17 918 0.9× 466 0.7× 369 0.7× 134 0.5× 207 1.0× 31 1.1k
Nadia R. P. W. Hutten Netherlands 14 695 0.7× 424 0.7× 385 0.7× 119 0.4× 167 0.8× 25 868
Amy Emerson United States 15 986 0.9× 411 0.6× 348 0.7× 184 0.7× 368 1.8× 23 1.1k
Alicia Danforth United States 7 1.3k 1.2× 569 0.9× 722 1.4× 108 0.4× 182 0.9× 10 1.3k
Allison A. Feduccia United States 13 1.1k 1.0× 435 0.7× 387 0.7× 185 0.7× 370 1.9× 16 1.2k
Nimmy Varghese Switzerland 15 996 0.9× 591 0.9× 622 1.2× 111 0.4× 89 0.4× 30 1.2k
Laura Ley Switzerland 14 844 0.8× 462 0.7× 516 1.0× 128 0.5× 72 0.4× 23 897
Ann T. Mithoefer United States 9 1.0k 1.0× 483 0.8× 313 0.6× 253 0.9× 410 2.0× 10 1.2k
Friederike Holze Switzerland 24 1.8k 1.7× 983 1.6× 1.1k 2.2× 194 0.7× 115 0.6× 45 1.9k
Peter Gasser Switzerland 11 1.5k 1.4× 769 1.2× 964 1.8× 85 0.3× 121 0.6× 21 1.6k

Countries citing papers authored by Patrick Vizeli

Since Specialization
Citations

This map shows the geographic impact of Patrick Vizeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Vizeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Vizeli more than expected).

Fields of papers citing papers by Patrick Vizeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Vizeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Vizeli. The network helps show where Patrick Vizeli may publish in the future.

Co-authorship network of co-authors of Patrick Vizeli

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Vizeli. A scholar is included among the top collaborators of Patrick Vizeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Vizeli. Patrick Vizeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartmann, Matthias, Yasmin Schmid, A. Becker, et al.. (2025). The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research. Journal of Psychopharmacology. 4126446288–4126446288.
2.
Straumann, Isabelle, Patrick Vizeli, Anne Eckert, et al.. (2025). Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants. Neuropsychopharmacology. 51(2). 476–485.
3.
Vizeli, Patrick, Erich Studerus, Friederike Holze, et al.. (2024). Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants. Translational Psychiatry. 14(1). 357–357. 9 indexed citations
4.
Avram, Mihai, Lydia Fortea, Αλεξάνδρα Κορδά, et al.. (2024). Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine. Molecular Psychiatry. 30(4). 1297–1307. 2 indexed citations
5.
Kuypers, Kim P. C., et al.. (2023). MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 128. 110843–110843. 12 indexed citations
6.
Avram, Mihai, Felix Müller, Katrin H. Preller, et al.. (2023). Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 9(5). 522–532. 8 indexed citations
7.
Wang, Zheng, Volker Röth, Friederike Holze, et al.. (2023). The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity. Neuropsychopharmacology. 48(8). 1175–1183. 21 indexed citations
8.
Vizeli, Patrick, Isabelle Straumann, Urs Duthaler, et al.. (2022). Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects. Frontiers in Pharmacology. 13. 906639–906639. 26 indexed citations
9.
Avram, Mihai, Felix Müller, Αλεξάνδρα Κορδά, et al.. (2022). Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 7(9). 885–894. 26 indexed citations
10.
Holze, Friederike, Laura Ley, Felix Müller, et al.. (2022). Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology. 47(6). 1180–1187. 142 indexed citations breakdown →
11.
Vizeli, Patrick, Isabelle Straumann, Friederike Holze, et al.. (2021). Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis. Scientific Reports. 11(1). 10851–10851. 40 indexed citations
12.
Holze, Friederike, Patrick Vizeli, Laura Ley, et al.. (2020). Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacology. 46(3). 537–544. 178 indexed citations
13.
Müller, Felix, Friederike Holze, Patrick C. Dolder, et al.. (2020). MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens. Neuropsychopharmacology. 46(3). 545–553. 23 indexed citations
14.
Holze, Friederike, Patrick Vizeli, Felix Müller, et al.. (2019). Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects. Neuropsychopharmacology. 45(3). 462–471. 182 indexed citations
15.
Vizeli, Patrick & Matthias E. Liechti. (2019). No Influence of Dopamine System Gene Variations on Acute Effects of MDMA. Frontiers in Psychiatry. 10. 755–755. 7 indexed citations
16.
Strajhar, Petra, Patrick Vizeli, Patrick C. Dolder, et al.. (2018). Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study. The Journal of Steroid Biochemistry and Molecular Biology. 186. 212–225. 14 indexed citations
17.
Vizeli, Patrick & Matthias E. Liechti. (2018). Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects. PLoS ONE. 13(6). e0199384–e0199384. 30 indexed citations
18.
Dolder, Patrick C., Petra Strajhar, Patrick Vizeli, et al.. (2017). Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects. Frontiers in Pharmacology. 8. 617–617. 37 indexed citations
19.
Vizeli, Patrick, Henriette E. Meyer zu Schwabedissen, & Matthias E. Liechti. (2017). No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA. European Journal of Clinical Pharmacology. 74(3). 275–283. 11 indexed citations
20.
Schmid, Yasmin, et al.. (2016). CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals. Pharmacogenetics and Genomics. 26(8). 397–401. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026